Neuroendocrine homeostasis after vagus nerve stimulation in rats

Psychoneuroendocrinology

Volumn 38, Issue 7, 2013, Pages 1067-1077

  Thrivikraman, K V ^a   Zejnelovic, Faketa ^a   Bonsall, Robert W ^a   Owens, Michael J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACTH; C Fos; Coping; Stress; Sympatho adrenal; Vagal afferents

Indexed keywords

ADRENALIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NORADRENALIN; PROTEIN C FOS;

ADENOHYPOPHYSIS; ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CYBERNETICS; ELECTROSTIMULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; JUGULAR VEIN; MALE; NEUROCYBERNETICS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PERFUSION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STARTLE REFLEX; VAGUS NERVE; VAGUS NERVE STIMULATION; VEIN CATHETERIZATION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; HOMEOSTASIS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84877927275     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.10.015     Document Type: Article

References (57)

1. Aalbers M.W., Rijkers K., van Winden L.A., Hoogland G., Vles J.S., Majoie H.J. Horner's syndrome: a complication of experimental carotid artery surgery in rats. Auton. Neurosci. 2009, 147:64-69.
2. Aguilera G., Nikodemova M., Wynn P.C., Catt K.J. Corticotropin releasing hormone receptors: two decades later. Peptides 2004, 25:319-329.
3. Appleyard S.M., Marks D., Kobayashi K., Okano H., Low M.J., Andresen M.C. Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus. J. Neurosci. 2007, 27:13292-13302.
4. Ardesch J.J., Buschman H.P., van der Burgh P.H., Wagener-Schimmel L.J., van der Aa H.E., Hageman G. Cardiac responses of vagus nerve stimulation: intraoperative bradycardia and subsequent chronic stimulation. Clin. Neurol. Neurosurg. 2007, 109:849-852.
5. Bajbouj M., Merkl A., Schlaepfer T.E., Frick C., Zobel A., Maier W., O'Keane V., Corcoran C., Adolfsson R., Trimble M., Rau H., Hoff H.J., Padberg F., Muller-Siecheneder F., Audenaert K., van den Abbeele D., Matthews K., Christmas D., Eljamel S., Heuser I. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J. Clin. Psychopharmacol. 2010, 30:273-281.
6. Barraco R., el-Ridi M., Ergene E., Parizon M., Bradley D. An atlas of the rat subpostremal nucleus tractus solitarius. Brain Res. Bull. 1992, 29:703-765.
7. Beekwilder J.P., Beems T. Overview of the clinical applications of vagus nerve stimulation. J. Clin. Neurophysiol. 2010, 27:130-138.
8. Berthoud H.R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 2000, 85:1-17.
9. Biggio F., Gorini G., Utzeri C., Olla P., Marrosu F., Mocchetti I., Follesa P. Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. Int. J. Neuropsychopharmacol. 2009, 12:1209-1221.
10. Conway C.R., Sheline Y.I., Chibnall J.T., Bucholz R.D., Price J.L., Gangwani S., Mintun M.A. Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder. Brain Stimul. 2012, 5:163-171.
11. Corcoran C., Connor T.J., O'Keane V., Garland M.R. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation 2005, 12:307-309.
12. Cunningham E.T., Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 1988, 274:60-76.
13. Cunningham J.T., Mifflin S.W., Gould G.G., Frazer A. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology 2008, 33:1884-1895.
14. De Herdt V., Puimege L., De Waele J., Raedt R., Wyckhuys T., El Tahry R., Libert C., Wadman W., Boon P., Vonck K. Increased rat serum corticosterone suggests immunomodulation by stimulation of the vagal nerve. J. Neuroimmunol. 2009, 212:102-105.
15. Dean C., Seagard J.L. Mapping of carotid baroreceptor subtype projections to the nucleus tractus solitarius using c-fos immunohistochemistry. Brain Res. 1997, 758:201-208.
16. Dorr A.E., Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 2006, 318:890-898.
17. Flandreau E.I., Ressler K.J., Owens M.J., Nemeroff C.B. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 2012, 37:27-38.
18. George M.S., Ward H.E., Ninan P.T., Pollack M., Nahas Z., Anderson B., Kose S., Howland R.H., Goodman W.K., Ballenger J.C. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008, 1:112-121.
19. Hartl D.M., Travagli J.P., Leboulleux S., Baudin E., Brasnu D.F., Schlumberger M. Clinical review: current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery. J. Clin. Endocrinol. Metab. 2005, 90:3084-3088.
20. Hosoi T., Okuma Y., Nomura Y. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R141-R147.
21. Jodo E., Chiang C., Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 1998, 83:63-79.
22. Kanter R.K., Strauss J.A., Sauro M.D. Comparison of neurons in rat medulla oblongata with fos immunoreactivity evoked by seizures, chemoreceptor, or baroreceptor stimulation. Neuroscience 1996, 73:807-816.
23. Kilts C.D., Gooch M.D., Knopes K.D. Quantitation of plasma catecholamines by on-line trace enrichment high performance liquid chromatography with electrochemical detection. J. Neurosci. Methods 1984, 11:257-273.
24. Koopman F.A., Stoof S.P., Straub R.H., Van Maanen M.A., Vervoordeldonk M.J., Tak P.P. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 2011, 17:937-948.
25. Kosel M., Brockmann H., Frick C., Zobel A., Schlaepfer T.E. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res. 2011, 191:153-159.
26. Krahl S.E., Senanayake S.S., Handforth A. Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 2001, 42:586-589.
27. Labiner D.M., Ahern G.L. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol. Scand. 2007, 115:23-33.
28. Lange G., Janal M.N., Maniker A., Fitzgibbons J., Fobler M., Cook D., Natelson B.H. Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial. Pain Med. 2011, 12:1406-1413.
29. Marca R.L., Waldvogel P., Thorn H., Tripod M., Wirtz P.H., Pruessner J.C., Ehlert U. Association between Cold Face Test-induced vagal inhibition and cortisol response to acute stress. Psychophysiology 2011, 48:420-429.
30. Marrosu F., Serra A., Maleci A., Puligheddu M., Biggio G., Piga M. Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res. 2003, 55:59-70.
31. Mickley G.A., Hoxha Z., Biada J.M., Kenmuir C.L., Bacik S.E. Acetaminophen self-administered in the drinking water increases the pain threshold of rats (Rattus norvegicus). J. Am. Assoc. Lab. Anim. Sci. 2006, 45:48-54.
32. Monnikes H., Ruter J., Konig M., Grote C., Kobelt P., Klapp B.F., Arnold R., Wiedenmann B., Tebbe J.J. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res. 2003, 966:253-264.
33. Mueller M.H., Kampitoglou D., Glatzle J., Hahn J., Kreis M.E. Systemic capsaicin inhibits neuronal activation in the brainstem during postoperative ileus in the mouse. Langenbecks Arch. Surg. 2006, 391:88-95.
34. Naritoku D.K., Terry W.J., Helfert R.H. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 1995, 22:53-62.
35. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., George M.S., Charney D.S., Brannan S.K. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006, 31:1345-1355.
36. Neylan T.C., Canick J.D., Hall S.E., Reus V.I., Sapolsky R.M., Wolkowitz O.M. Cortisol levels predict cognitive impairment induced by electroconvulsive therapy. Biol. Psychiatry 2001, 50:331-336.
37. O'Keane V., Dinan T.G., Scott L., Corcoran C. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Biol. Psychiatry 2005, 58:963-968.
38. Owens M.J., Knight D.L., Ritchie J.C., Nemeroff C.B. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. J. Pharmacol. Exp. Ther. 1991, 256:795-800.
39. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
40. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev. 2001, 22:502-548.
41. Paintal A.S. Vagal afferent fibres. Ergeb. Physiol. 1963, 52:74-156.
42. Palazidou E. The neurobiology of depression. Br. Med. Bull. 2012, 101:127-145.
43. Peters J.H., McDougall S.J., Fawley J.A., Andresen M.C. TRPV1 marks synaptic segregation of multiple convergent afferents at the rat medial solitary tract nucleus. PLoS ONE 2011, 6:e25015.
44. Prodanov D., Marani E., Holsheimer J. Functional electric stimulation for sensory and motor functions: progress and problems. Biomed. Rev. 2003, 14:23-50.
45. Rush A.J., Siefert S.E. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp. Neurol. 2009, 219:36-43.
46. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., Johnson C.R., Seidman S., Giller C., Haines S., Simpson R.K., Goodman R.R. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713-728.
47. Tehovnik E.J. Electrical stimulation of neural tissue to evoke behavioral responses. J. Neurosci. Methods 1996, 65:1-17.
48. Thrivikraman K.V., Carlson D.E., Gann D.S. Locus coeruleus monoaminergic activity and plasma corticotropin after hemorrhage in cats. Am. J. Physiol. 1988, 254:R289-R295.
49. Thrivikraman K.V., Su Y., Plotsky P.M. Patterns of Fos-immunoreactivity in the CNS induced by repeated hemorrhage in conscious rats: correlations with pituitary-adrenal axis activity. Stress 1997, 2:145-158.
50. Thrivikraman K.V., Nemeroff C.B., Plotsky P.M. Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitry. Brain Res. 2000, 870:87-101.
51. Thrivikraman K.V., Huot R.L., Plotsky P.M. Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. Brain Res. Brain Res. Protoc. 2002, 10:84-94.
52. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 2009, 10:397-409.
53. Weber C.S., Thayer J.F., Rudat M., Wirtz P.H., Zimmermann-Viehoff F., Thomas A., Perschel F.H., Arck P.C., Deter H.C. Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers. Eur. J. Appl. Physiol. 2010, 109:201-211.
54. Welberg L.A., Kinkead B., Thrivikraman K., Huerkamp M.J., Nemeroff C.B., Plotsky P.M. Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. J. Am. Assoc. Lab. Anim. Sci. 2006, 45:13-20.
55. Woodbury J.W., Woodbury D.M. Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording. Pacing Clin. Electrophysiol. 1991, 14:94-107.
56. Young E.A., Altemus M., Lopez J.F., Kocsis J.H., Schatzberg A.F., DeBattista C., Zubieta J.K. HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology 2004, 29:1198-1204.
57. Yousfi-Malki M., Puizillout J.J. Induction of Fos-like protein in neurons of the medulla oblongata after electrical stimulation of the vagus nerve in anesthetized rabbit. Brain Res. 1994, 635:317-322.